Androgenetic alopecia at various ages and prostate cancer risk in an equal-access multiethnic case-control series of veterans

Cancer Causes and Control

Volumn 24, Issue 5, 2013, Pages 1045-1052

  Thomas, Jean Alfred ^a,b   Antonelli, Jodi A ^a,b   Banez, Lionel L ^b   Hoyo, Catherine ^c   Grant, Delores ^d   Demark Wahnefried, Wendy ^e   Platz, Elizabeth A ^f,g,h   Gerber, Leah ^a,b   Shuler, Kathryn ^b   Eyoh, Enwono ^a,b   Calloway, Elizabeth ^a,b   Freedland, Stephen J ^a,b,c  

^a DUKE UNIVERSITY   (United States)

^b DURHAM VA MEDICAL CENTER   (United States)

^c DUKE UNIVERSITY MEDICAL CENTER   (United States)

^d JLC Biomed/Biotech Res Institute   (United States)

^e UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^f JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^g DEPARTMENT OF PATHOLOGY   (United States)

^h JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

Androgenetic alopecia; High grade disease; Prostate cancer

Indexed keywords

ADULT; AGE; AGED; ARTICLE; CANCER GRADING; CANCER RISK; CASE CONTROL STUDY; CONTROLLED STUDY; DISEASE ASSOCIATION; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MALE TYPE ALOPECIA; ONSET AGE; PRIORITY JOURNAL; PROSTATE CANCER; SELF REPORT; TUMOR BIOPSY; VETERAN;

AGE OF ONSET; AGED; ALOPECIA; ANDROGENS; BIOPSY; CASE-CONTROL STUDIES; HUMANS; MALE; MIDDLE AGED; PROSTATIC NEOPLASMS; RISK FACTORS;

EID: 84892818044     PISSN: 09575243     EISSN: 15737225     Source Type: Journal    
DOI: 10.1007/s10552-013-0182-4     Document Type: Article

References (31)

1. Kaaks R, Lukanova A, Sommersberg B (2000) Plasma androgens, IGF-1, body size, and prostate cancer risk: a synthetic review. Prostate Cancer Prostatic Dis 3:157-172
2. Platz EA, Giovannucci E (2004) The epidemiology of sex steroid hormones and their signaling and metabolic pathways in the etiology of prostate cancer. J Steroid Biochem Mol Biol 92: 237-253
3. Travis RC, Key TJ, Allen NE, Appleby PN, Roddam AW, Rinaldi S et al. (2007) Serum androgens and prostate cancer among 643 cases and 643 controls in the European prospective investigation into cancer and nutrition. Int J Cancer 121:1331-1338
4. Marks LS, Mazer NA, Mostaghel E, Hess DL, Dorey FJ, Epstein JI et al. (2006) Effect of testosterone replacement therapy on prostate tissue in men with late-onset hypogonadism: a randomized controlled trial. JAMA 296:2351-2361
5. Ellis JA, Sinclair R, Harrap SB (2002) Androgenetic alopecia: pathogenesis and potential for therapy. Expert Rev Mol Med 4:1-11
6. Otberg N, Finner AM, Shapiro J (2007) Androgenetic alopecia. Endocrinol Metab Clin North Am 36:379-398
7. Hamilton JB (1951) Patterned loss of hair in man; types and incidence. Ann N Y Acad Sci 53:708-728
8. Oh BR, Kim SJ, Moon JD, Kim HN, Kwon DD, Won YH et al. (1998) Association of benign prostatic hyperplasia with male pattern baldness. Urology 51:744-748
9. Rapaport MJ (2004) Follow-up of 1 mg finasteride treatment of male pattern baldness-difference between clinical trials and private office follow-up: influences on prescribing habits evaluated. Dermatol Surg 30:761-763
10. Thompson IM, Klein EA, Lippman SM, Coltman CA, Djavan B (2003) Prevention of prostate cancer with finasteride: US/European perspective. Eur Urol 44:650-655
11. Demark-Wahnefried W, Schildkraut JM, Thompson D, Lesko SM, McIntyre L, Schwingl P et al. (2000) Early onset baldness and prostate cancer risk. Cancer Epidemiol Biomarkers Prev 9: 325-328
12. Giles GG, Severi G, Sinclair R, English DR, McCredie MR, Johnson W et al. (2002) Androgenetic alopecia and prostate cancer: findings from an Australian case-control study. Cancer Epidemiol Biomarkers Prev 11:549-553
13. Wright JL, Page ST, Lin DW, Stanford JL (2010) Male pattern baldness and prostate cancer risk in a population-based casecontrol study. Cancer Epidemiol 34:131-135
14. Hawk E, Breslow RA, Graubard BI (2000) Male pattern baldness and clinical prostate cancer in the epidemiologic follow-up of the first National Health and Nutrition Examination Survey. Cancer Epidemiol Biomarkers Prev 9:523-527
15. Greenwald P, Damon A, Kirmss V, Polan AK (1974) Physical and demographic features of men before developing cancer of the prostate. J Natl Cancer Inst 53:341-346
16. Hsieh CC, Thanos A, Mitropoulos D, Deliveliotis C, Mantzoros CS, Trichopoulos D (1999) Risk factors for prostate cancer: a case-control study in Greece. Int J Cancer 80:699-703
17. Yassa M, Saliou M, De Rycke Y, Hemery C, Henni M, Bachaud JM et al. (2011) Male pattern baldness and the risk of prostate cancer. Ann Oncol 22:1824-1827
18. Cremers RG, Aben KK, Vermeulen SH, den Heijer M, van Oort IM, Kiemeney LA (2010) Androgenic alopecia is not useful as an indicator of men at high risk of prostate cancer. Eur J Cancer 46:3294-3299
19. Hsing AW, Comstock GW (1993) Serological precursors of cancer: serum hormones and risk of subsequent prostate cancer. Cancer Epidemiol Biomarkers Prev 2:27-32
20. Gann PH, Hennekens CH, Ma J, Longcope C, Stampfer MJ (1996) Prospective study of sex hormone levels and risk of prostate cancer. J Natl Cancer Inst 88:1118-1126
21. Platz EA, Leitzmann MF, Rifai N, Kantoff PW, Chen YC, Stampfer MJ et al. (2005) Sex steroid hormones and the androgen receptor gene CAG repeat and subsequent risk of prostate cancer in the prostate-specific antigen era. Cancer Epidemiol Biomarkers Prev 14:1262-1269
22. Stough D, Stenn K, Haber R, Parsley WM, Vogel JE, Whiting DA et al. (2005) Psychological effect, pathophysiology, and management of androgenetic alopecia in men. Mayo Clin Proc 80:1316-1322
23. Randall VA (2007) Hormonal regulation of hair follicles exhibits a biological paradox. Semin Cell Dev Biol 18:274-285
24. Ellis JA, Stebbing M, Harrap SB (2001) Polymorphism of the androgen receptor gene is associated with male pattern baldness. J Invest Dermatol 116:452-455
25. Lesko SM, Rosenberg L, Shapiro S (1993) A case-control study of baldness in relation to myocardial infarction in men. JAMA: J Am Med Assoc 269:998-1003
26. Shahar E, Heiss G, Rosamond WD, Szklo M (2008) Baldness and myocardial infarction in men: the atherosclerosis risk in communities study. Am J Epidemiol 167:676-683
27. Schnohr P, Lange P, Nyboe J, Appleyard M, Jensen G (1995) Gray hair, baldness, and wrinkles in relation to myocardial infarction: the Copenhagen city heart study. Am Heart J 130: 1003-1010
28. Littman AJ, White E (2005) Reliability and validity of selfreported male balding patterns for use in epidemiologic studies. Ann Epidemiol 15:771-772
29. Taylor R, Matassa J, Leavy JE, Fritschi L (2004) Validity of self reported male balding patterns in epidemiological studies. BMC Public Health 4:60
30. Signorello LB, Wuu J, Hsieh C, Tzonou A, Trichopoulos D, Mantzoros CS (1999) Hormones and hair patterning in men: a role for insulin-like growth factor 1? J Am Acad Dermatol 40:200-203
31. Platz EA, Pollak MN, Willett WC, Giovannucci E (2000) Vertex balding, plasma insulin-like growth factor 1, and insulin-like growth factor binding protein 3. J Am Acad Dermatol 42: 1003-1007